TNFRSF11B and neoplasm: Although the precise molecular pathway that induces OPG in tumor-primed B cells remains to be defined, these data position OPG+ B cells as active mediators of osteoimmune protection and identify T cell–B cell cross-talk as a critical upstream licensing step.